UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Age and acute myeloid leukemia

Blood, 2006-05, Vol.107 (9), p.3481-3485

2006

Volltextzugriff (PDF)

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial

Blood, 2017-06, Vol.129 (25), p.3304-3313

2017

Volltextzugriff (PDF)

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

Blood, 2000-12, Vol.96 (13), p.4075-4083

2000

Volltextzugriff (PDF)

Lasting anxiogenic effects of feline predator stress in mice: Sex differences in vulnerability to stress and predicting severity of anxiogenic response from the stress experience

Physiology & behavior, 2006-06, Vol.88 (1), p.12-29

2006

Volltextzugriff (PDF)

Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431

Archives of pathology & laboratory medicine (1976), 2020-04, Vol.144 (4), p.466-472

2020

Volltextzugriff (PDF)

Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia

Leukemia research, 2018-02, Vol.65, p.67-73

2018

Volltextzugriff (PDF)

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience

Blood, 2001-06, Vol.97 (12), p.3727-3732

2001

Volltextzugriff (PDF)

11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: Report from an International Workshop

Genes chromosomes & cancer, 2002-04, Vol.33 (4), p.362-378

2002

Volltextzugriff (PDF)

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421

Blood, 2006-02, Vol.107 (4), p.1315-1324

2006

Volltextzugriff (PDF)

Quantitative Assessment of Myeloid Nuclear Differentiation Antigen Distinguishes Myelodysplastic Syndrome From Normal Bone Marrow

American journal of clinical pathology, 2011-03, Vol.135 (3), p.380-385

2011

Volltextzugriff (PDF)

Molecular biology of Rh proteins and relevance to molecular medicine

Expert reviews in molecular medicine, 2006-06, Vol.8 (13), p.1-20

2006

Volltextzugriff (PDF)

Multiplex imaging reveals spatially resolved DNA‐damage response neighborhoods in TP53‐mutated myelodysplastic neoplasms

The Journal of pathology, 2024-07, Vol.263 (3), p.386-395

2024

Volltextzugriff (PDF)

PCR detection of Histoplasma capsulatum var. capsulatum in whole blood of a renal transplant patient with disseminated histoplasmosis

Annals of clinical and laboratory science, 2009, Vol.39 (4), p.409-412

2009

Volltextzugriff (PDF)

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)

American journal of hematology, 2007-12, Vol.82 (12), p.1056-1062

2007

Volltextzugriff (PDF)

Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase

Blood, 2002-09, Vol.100 (5), p.1910-1912

2002

Volltextzugriff (PDF)

Long‐term survival of infants with idiopathic myelofibrosis

British journal of haematology, 2000-05, Vol.109 (2), p.459-462

2000

Volltextzugriff (PDF)

A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617

Leukemia research, 2000-07, Vol.24 (7), p.567-574

2000

Volltextzugriff (PDF)

Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study

Blood, 1999-08, Vol.94 (3), p.1086-1099

1999

Volltextzugriff (PDF)

Acute myeloid leukemia in the elderly : Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A southwest oncology group study

Blood, 1997-05, Vol.89 (9), p.3323-3329

1997

Volltextzugriff (PDF)

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

Blood, 2002-12, Vol.100 (12), p.3869-3876

2002

Volltextzugriff (PDF)

Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapy

Journal of pediatric hematology/oncology, 2001-06, Vol.23 (5), p.309-311

2001

Volltextzugriff (PDF)

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin

Blood, 2000-11, Vol.96 (9), p.2981-2986

2000

Volltextzugriff (PDF)

A Randomized Investigation of High-Dose Versus Standard-Dose Cytosine Arabinoside With Daunorubicin in Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study

Blood, 1996-10, Vol.88 (8), p.2841-2851

1996

Volltextzugriff (PDF)

Trisomy 11: an association with stem/progenitor cell immunophenotype

British journal of haematology, 1995-06, Vol.90 (2), p.266-273

1995

Volltextzugriff (PDF)

Clinical and Molecular Characterization of a Rare Syndrome of Acute Promyelocytic Leukemia Associated With Translocation (11; 17)

Blood, 1995-02, Vol.85 (4), p.1083-1094

1995

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Aktive Filter

SpracheSpanisch

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(241)

Publikationsform

Artikel
(294)

Sprache

Englisch
(294)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Age and acute myeloid leukemia

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

Lasting anxiogenic effects of feline predator stress in mice: Sex differences in vulnerability to stress and predicting severity of anxiogenic response from the stress experience

Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431

Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience

11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: Report from an International Workshop

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421

Quantitative Assessment of Myeloid Nuclear Differentiation Antigen Distinguishes Myelodysplastic Syndrome From Normal Bone Marrow

Molecular biology of Rh proteins and relevance to molecular medicine

Multiplex imaging reveals spatially resolved DNA‐damage response neighborhoods in TP53‐mutated myelodysplastic neoplasms

PCR detection of Histoplasma capsulatum var. capsulatum in whole blood of a renal transplant patient with disseminated histoplasmosis

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG‐9500)

Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase

Long‐term survival of infants with idiopathic myelofibrosis

A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617

Frequency and Clinical Significance of the Expression of the Multidrug Resistance Proteins MDR1/P-Glycoprotein, MRP1, and LRP in Acute Myeloid Leukemia. A Southwest Oncology Group Study

Acute myeloid leukemia in the elderly : Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A southwest oncology group study

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapy

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin

A Randomized Investigation of High-Dose Versus Standard-Dose Cytosine Arabinoside With Daunorubicin in Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study

Trisomy 11: an association with stem/progenitor cell immunophenotype

Clinical and Molecular Characterization of a Rare Syndrome of Acute Promyelocytic Leukemia Associated With Translocation (11; 17)

Aktive Filter

Suchergebnisse filtern